Recombinant CD22 (Pinatuzumab Biosimilar) antibody
Research Grade
Reactivity: Human
ELISA
Host: Humanized
Monoclonal
unconjugated
Recombinant Antibody
1 image
-
- Target See all CD22 (Pinatuzumab Biosimilar) products
- CD22 (Pinatuzumab Biosimilar)
- Antibody Type
- Recombinant Antibody
- Reactivity
- Human
-
Host
-
Humanized
-
Clonality
- Monoclonal
-
Conjugate
- This CD22 (Pinatuzumab Biosimilar) antibody is un-conjugated
- Application
- ELISA
- Purpose
- Anti-CD22 (pinatuzumab biosimilar) mAb
- Characteristics
- ACD22-VCMMAE, DCDT2980S, FCU2803, RG-7593, RO5541072-000
- Purification
- Purified from cell culture supernatant by affinity chromatography
- Grade
- Research Grade
- Isotype
- IgG1
-
-
- Application Notes
- ELISA 1:5000-10000
- Comment
-
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Reconstitute with deionized water
- Buffer
- Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.
- Storage
- -20 °C,-80 °C
- Storage Comment
- Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.
- Expiry Date
- 12 months
-
- Target
- CD22 (Pinatuzumab Biosimilar)
- Abstract
- CD22 (Pinatuzumab Biosimilar) Products
- Target Type
- Biosimilar
- Background
- Synonyms: CD22, SIGLEC2, BL-CAM, SIGLEC-2, Siglec2, SIGLEC2FLJ22814
- Gene ID
- 933
- UniProt
- P20273
-
You are here:
